PLAU and Familial prostate cancer: It has been demonstrated that prostate cancer cells facilitate new bone formation by secreting parathyroid hormone-related protein (PTHrP) [57], urokinase-type plasminogen activator (uPA) [58], or prostate-specific antigen (PSA) [59].